Literature DB >> 28551108

Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1.

Wei Chen1, Anupama Tuladhar1, Shantelle Rolle1, Yanhao Lai1, Freddy Rodriguez Del Rey1, Cristian E Zavala1, Yuan Liu2, Kathleen S Rein3.   

Abstract

Karenia brevis, the Florida red tide dinoflagellate produces a suite of neurotoxins known as the brevetoxins. The most abundant of the brevetoxins PbTx-2, was found to inhibit the thioredoxin-thioredoxin reductase system, whereas the PbTx-3 has no effect on this system. On the other hand, PbTx-2 activates the reduction of small disulfides such as 5,5'-dithio-bis-(2-nitrobenzoic acid) by thioredoxin reductase. PbTx-2 has an α, β-unsaturated aldehyde moiety which functions as an efficient electrophile and selenocysteine conjugates are readily formed. PbTx-2 blocks the inhibition of TrxR by the inhibitor curcumin, whereas curcumin blocks PbTx-2 activation of TrxR. It is proposed that the mechanism of inhibition of thioredoxin reduction is via the formation of a Michael adduct between selenocysteine and the α, β-unsaturated aldehyde moiety of PbTx-2. PbTx-2 had no effect on the rates of reactions catalyzed by related enzymes such as glutathione reductase, glutathione peroxidase or glutaredoxin.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brevetoxin; Karenia brevis; Thioredoxin; Thioredoxin reductase

Mesh:

Substances:

Year:  2017        PMID: 28551108      PMCID: PMC5623065          DOI: 10.1016/j.taap.2017.05.027

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  51 in total

1.  Crystal structure of the human thioredoxin reductase-thioredoxin complex.

Authors:  Karin Fritz-Wolf; Sebastian Kehr; Michaela Stumpf; Stefan Rahlfs; Katja Becker
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

2.  Selective selenol fluorescent probes: design, synthesis, structural determinants, and biological applications.

Authors:  Baoxin Zhang; Chunpo Ge; Juan Yao; Yaping Liu; Huichen Xie; Jianguo Fang
Journal:  J Am Chem Soc       Date:  2015-01-05       Impact factor: 15.419

3.  Neurotoxic shellfish poisoning and brevetoxin metabolites: a case study from Florida.

Authors:  M A Poli; S M Musser; R W Dickey; P P Eilers; S Hall
Journal:  Toxicon       Date:  2000-07       Impact factor: 3.033

4.  Selenium in thioredoxin reductase: a mechanistic perspective.

Authors:  Brian M Lacey; Brian E Eckenroth; Stevenson Flemer; Robert J Hondal
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

5.  Brevetoxins 2, 3, 6, and 9 show variability in potency and cause significant induction of DNA damage and apoptosis in Jurkat E6-1 cells.

Authors:  Rachel N Murrell; James E Gibson
Journal:  Arch Toxicol       Date:  2009-06-18       Impact factor: 5.153

6.  The human health effects of Florida red tide (FRT) blooms: an expanded analysis.

Authors:  Porter Hoagland; Di Jin; Andrew Beet; Barbara Kirkpatrick; Andrew Reich; Steve Ullmann; Lora E Fleming; Gary Kirkpatrick
Journal:  Environ Int       Date:  2014-04-14       Impact factor: 9.621

Review 7.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

8.  Production of nitric oxide by peripheral blood mononuclear cells from the Florida manatee, Trichechus manatus latirostris.

Authors:  Catherine J Walsh; Joyce E Stuckey; Heather Cox; Brett Smith; Christina Funke; Jeff Stott; Clarence Colle; Joseph Gaspard; Charles A Manire
Journal:  Vet Immunol Immunopathol       Date:  2007-06-13       Impact factor: 2.046

9.  Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma.

Authors:  Lora E Fleming; Barbara Kirkpatrick; Lorraine C Backer; Judy A Bean; Adam Wanner; Dana Dalpra; Robert Tamer; Julia Zaias; Yung Sung Cheng; Richard Pierce; Jerome Naar; William Abraham; Richard Clark; Yue Zhou; Michael S Henry; David Johnson; Gayl Van De Bogart; Gregory D Bossart; Mark Harrington; Daniel G Baden
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

10.  Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).

Authors:  Catherine J Walsh; Stephanie R Leggett; Kathryn Strohbehn; Richard H Pierce; John W Sleasman
Journal:  Mar Drugs       Date:  2008-06-10       Impact factor: 5.118

View more
  5 in total

1.  Effectors of thioredoxin reductase: Brevetoxins and manumycin-A.

Authors:  Anupama Tuladhar; Robert J Hondal; Ricardo Colon; Elyssa L Hernandez; Kathleen S Rein
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2018-11-23       Impact factor: 3.228

2.  Brevetoxin (PbTx-2) influences the redox status and NPQ of Karenia brevis by way of thioredoxin reductase.

Authors:  Wei Chen; Ricardo Colon; J William Louda; Freddy Rodriguez Del Rey; Michaella Durham; Kathleen S Rein
Journal:  Harmful Algae       Date:  2018-01       Impact factor: 4.273

3.  Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1).

Authors:  Anupama Tuladhar; Kathleen S Rein
Journal:  ACS Med Chem Lett       Date:  2018-03-05       Impact factor: 4.345

4.  Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines.

Authors:  Jianming Liao; Linlin Wang; Zhongxi Wu; Zhixiang Wang; Jun Chen; Yucheng Zhong; Feng Jiang; Yuanyuan Lu
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

5.  Immune Modulating Brevetoxins: Monocyte Cytotoxicity, Apoptosis, and Activation of M1/M2 Response Elements Is Dependent on Reactive Groups.

Authors:  Jennifer R McCall; Kathryn T Sausman; Devon M Keeler; Ariel P Brown; Stephanie L Turrise
Journal:  Mar Drugs       Date:  2022-03-29       Impact factor: 6.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.